0 Комментарии
0 Поделились
1057 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Ulcerative Colitis Drug Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2028Developments in biosimilars, increasing prevalence rate of Ulcerative Colitis, and changing lifestyle have resulted in boosting the Ulcerative Colitis Drug market. The global ulcerative colitis drug market is forecast to reach USD 10.69 Billion by 2028, according to a new report by Reports and Data. Ulcerative colitis (UC) can be defined as an inflammatory bowel...0 Комментарии 0 Поделились 1930 Просмотры 0 предпросмотр
- Ulcerative Colitis Market Analysis: Key Players Leading the Charge (Updated 2024)Ulcerative Colitis Market: Growing Need for Effective Solutions Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) affecting the large intestine. The global ulcerative colitis market reflects the increasing need for effective diagnosis, treatment, and management of this condition. According to April 2024 market research report, the global Ulcerative Colitis Market Size was...0 Комментарии 0 Поделились 140 Просмотры 0 предпросмотр
- Ulcerative Colitis Market Regional Analysis, Key Players Profiles and Future ProspectsThe high cost of ulcerative colitis treatment is another significant factor that hampers the growth of the market. The cost of drugs used to treat ulcerative colitis can be very high, making it difficult for many patients to afford treatment. For example, biologics, which are often prescribed to patients with moderate to severe ulcerative colitis, can cost tens of thousands of dollars per year....0 Комментарии 0 Поделились 1082 Просмотры 0 предпросмотр
- Ulcerative Colitis Market to Record Significant Revenue Growth During the Forecast Period 2022-2028The Ulcerative Colitis Market refers to the market for drugs, biologics, and other treatments used in the management of ulcerative colitis, a chronic inflammatory bowel disease that affects the colon and rectum. The market is driven by the increasing prevalence of ulcerative colitis, which is estimated to affect around 1.6 million Americans, as well as a growing aging population. According to a...0 Комментарии 0 Поделились 1156 Просмотры 0 предпросмотр
- Ulcerative Colitis Medication Market Size, Share, Key Players, Growth Trend, and Forecast, 2023–2030Ulcerative Colitis Medication (UC) is a chronic inflammatory bowel disease that affects the colon and rectum. The disease is characterized by ulcerations, inflammation, and bleeding in the colonic mucosa, which leads to diarrhea and abdominal pain. The market for UC drugs has been growing in recent years due to the increasing prevalence of UC, as well as advancements in drug development and...0 Комментарии 0 Поделились 1180 Просмотры 0 предпросмотр
- Ulcerative Colitis Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)Ulcerative Colitis Treatment Market Ulcerative Colitis Treatment Market Surges, Projected to Reach US$ 11.1 Billion by 2030 Global Market Hits US$ 6.9 Billion in 2022, Expects 6.3% CAGR During 2024-2031 The global ulcerative colitis treatment market has demonstrated robust growth, reaching a valuation of US$ 6.9 billion in 2022, with projections soaring to US$ 11.1 billion by 2030. The...0 Комментарии 0 Поделились 541 Просмотры 0 предпросмотр
- Ulcerative Colitis Uncovered: A Comprehensive Report on Market Size, Share, and Trends in TherapeuticsThe global ulcerative colitis therapeutics market is anticipated to rise at a CAGR of 5.1% from 2021 to 2027. In 2020, revenue from ulcerative colitis therapeutics was US$ 5.6 Bn, which is expected to reach US$ 7.9 Bn by 2027. The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing...0 Комментарии 0 Поделились 797 Просмотры 0 предпросмотр
- Enrofloxacin: A Broad Spectrum Antibacterial DrugChemical Properties and Mechanism of ActionEnrofloxacin contains a bicyclic fluoroquinolone core structure which is responsible for its bactericidal properties. It works by inhibiting the bacterial enzymes DNA gyrase and topoisomerase IV which are required for DNA replication, transcription, repair and recombination. This leads to bacterial cell death. Chemically, enrofloxacin is a white to...0 Комментарии 0 Поделились 545 Просмотры 0 предпросмотр
- Remicade Biosimilars Market Estimated To Witness High Growth Owing To Rising Prevalence Of Autoimmune DiseasesSWOT Analysis Strength: Remicade biosimilars market has strong growth potential due to the patent expiry of Remicade leading to availability of affordable treatment options. Biosimilars have almost similar efficacy as reference biologics with much lower costs. Rapid regulatory approvals for biosimilars are catalyzing their commercialization. Weakness: Development of biosimilars require...0 Комментарии 0 Поделились 858 Просмотры 0 предпросмотр
- Sulfasalazine: A History of Treatment for Inflammatory Bowel DiseaseDiscovery and Mechanism of ActionIt was first synthesized in the 1930s as a combination of sulfapyridine, an antibacterial sulfonamide antibiotic, and 5-aminosalicylic acid (5-ASA). Early clinical trials in the 1940s found that it was effective for treating ulcerative colitis. However, its exact mechanism of action for treating inflammatory bowel disease (IBD) was not fully understood until...0 Комментарии 0 Поделились 114 Просмотры 0 предпросмотр
- Understanding Inflammatory Bowel DiseaseInflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. The two main types of IBD are ulcerative colitis and Crohn's disease. While the exact causes of IBD are unknown, it is believed to result from an abnormal response of the immune system to environmental triggers in genetically susceptible individuals. IBD can cause chronic inflammation and...0 Комментарии 0 Поделились 594 Просмотры 0 предпросмотр
Расширенные страницы